Stock Rating Upgrade
In the last week the Value Trend Rating for Zimmer Biomet Holdings Inc (NYSE: ZBH) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Zimmer Biomet Holdings Inc (NYSE: ZBH) stock declined modestly by -1.7% on 2/7/25. The stock closed at $100.93. Moreover, this decline was accompanied by unusually high trading volume at 166% of normal. The stock has performed in line with the market over the last nine months and has declined -8.8% during the last week.
Current PriceTarget Research Rating
Zimmer Biomet Holdings has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Zimmer Biomet Holdings has a neutral Appreciation Score of 52 and a neutral Power Rating of 43, triggering the Low Neutral Value Trend Rating.
Be the first to comment